diabetes

Not all fats affect your body the same way. Researchers found that palmitic acid, a saturated fat common in many foods, may contribute to insulin resistance and type 2 diabetes by triggering inflammation, toxic fat buildup, and cellular stress. In contrast, oleic acid—the heart-healthy fat abundant in olive oil—appears to help protect insulin function and may even counter some of the harmful effe…

For many years, doctors treated diabetes and dementia as two separate health problems. Diabetes was mainly seen as a disease that affects blood sugar and damages organs such as the heart, kidneys, and eyes. Dementia was viewed as a disorder of memory and thinking that happens in the brain. Today, scientists are finding that these […] The post Could Controlling Diabetes Help Prevent Dementia? appe…

For millions of people living with type 2 diabetes, controlling blood sugar can be a daily challenge. The disease happens when the body no longer responds properly to insulin or cannot make enough of it. As a result, glucose, a type of sugar that the body uses for energy, builds up in the bloodstream. Over […] The post New Diabetes Pill Could Control Blood Sugar and Reduce Weight Better appeared …

Scientists are increasingly discovering that diabetes and dementia are closely connected. For many years, doctors thought of diabetes mainly as a disease that affects blood sugar, the heart, kidneys, and eyes. Dementia, on the other hand, was seen as a completely separate brain disorder. However, new studies are showing that the two conditions influence each […] The post 10 Surprising Ways Diabet…

Many people enjoy taking a nap during the day. A short nap can help people feel refreshed, improve alertness, and provide extra energy. However, new research suggests that long daytime naps may not always be harmless, especially for people living with type 2 diabetes. Scientists have found that people with type 2 diabetes who nap […] The post Long Naps Linked to Fatty Liver Disease in Type 2 Diab…

Obesity and type 2 diabetes affect hundreds of millions of people around the world. These conditions are known for causing problems with blood sugar and body weight, but their effects reach far beyond that. People with obesity and type 2 diabetes also have a much higher risk of developing heart disease, strokes, and other serious […] The post These drugs Can Protect Blood Vessels in Obesity and T…

For decades, doctors have treated skin diseases and metabolic disorders as separate medical problems. Skin specialists focused on rashes and inflammation, while diabetes doctors concentrated on blood sugar and weight management. New research suggests these conditions may be more closely connected than previously believed. One group of medicines at the center of this new research […] The post A Di…

Background/ObjectivesWe have previously demonstrated that the natural alkaloid Cepharanthine (Ceph) reduces renal injury in streptozotocin (STZ)-induced insulin-deficient diabetic rats via antioxidant and anti-inflammatory mechanisms. However, the hypoglycemic mechanism of Ceph remains unclear. We hypothesize that Ceph reduces blood glucose in STZ-induced insulin-deficient diabetic rats via resto…

Precise regulation of gene expression and drug delivery is required to maximize therapeutic efficacy and minimize adverse side effects. Several studies indicate a potential role for targeted gene and drug delivery in the precision therapy of type 2 diabetes and other diseases. This review summarizes recent knowledge on the cell-penetrating function and membrane-crossing roles of cell-penetrating …

ObjectivesThis study systematically assessed the efficacy and safety of 15 incretin-based therapies (IBTs) for type 2 diabetes mellitus (T2DM), including mono- (GLP-1RA), dual- (GIP/GLP-1RA or GLP-1/GCGR), and triple- (GIP/GLP-1/GCGR) receptor agonists, and explored how dosage and treatment duration affect clinical outcomes to support individualized treatment decisions.MethodsA systematic review …

The Leapfrog Group and the American Diabetes Association(r) (ADA) announced that UI Health has received national designation as a Recognized Leader in Caring for People Living with Diabetes. UI Health made the list of just 37 hospitals across 14 states earning this recognition for a strong commitment to the safety and well-being of hospitalized people living with diabetes. An estimated 30% of inp…

Type 2 diabetes mellitus (T2DM) significantly increases colorectal cancer (CRC) risk, driven by shared metabolic and inflammatory pathways. As lifelong glucose-lowering medications are routinely used in T2DM, their pharmacological activities and associated oncological effects have become critical for safety and repurposing. This review systematically summarizes the pharmacological mechanisms, epi…

(Nature) – The shot reduced insulin use for people with type 1 diabetes and another autoimmune condition. A century-old vaccine against tuberculosis helps to regulate blood sugar in people with certain types of diabetes, such that they can reduce their … Read More

New research suggests that a common second-line blood pressure treatment may not be as kidney-friendly as previously assumed for some people with diabetic kidney disease. Blood pressure control is one of the most important ways to slow kidney damage in people with type 2 diabetes. But new research suggests that one of the most commonly [...]

For people living with diabetes, even a small wound on the foot can become a serious medical problem. Because diabetes can damage nerves and reduce blood circulation, cuts and sores may heal slowly and become infected. In severe cases, tissue can die, making amputation necessary. Doctors often say that timing is critical because early treatment […] The post New Patch Can Track Dangerous Diabetic …

Semaglutide has become one of the most talked-about medicines in recent years because of its ability to help people with type 2 diabetes and obesity lose weight. Doctors have welcomed its benefits for blood sugar control and weight management, but questions remain about how significant weight loss affects other parts of the body, especially bones. […] The post This Diabetes Drug May Lower Bone Fr…

Critical Path Institute® (C-Path), through its Type 1 Diabetes Consortium, today reaffirmed its commitment to strengthening the regulatory-science and evidence infrastructure needed to enable the next phase of therapeutic innovation across multiple stages of type 1 diabetes (T1D).

A new oral GLP-1 medication helped people with type 2 diabetes dramatically improve blood sugar control and lose weight in a major clinical trial. The results suggest that highly effective diabetes treatments may soon become available in a much more convenient pill form.

Scientific Reports, Published online: 15 June 2026; doi:10.1038/s41598-026-55921-y Retinal blood flow increases with diabetic retinopathy severity in type 2 diabetes: a cross-sectional study using laser doppler velocimetry